| View |
|
DR-XY 42062
|
Tolvaptan
|
Samsca
|
15mg
|
Tablet
|
-
|
Korea Otsuka Pharmaceutical Co., Ltd.
|
Korea
|
-
|
30 March 2022
|
23 April 2026
|
| View |
|
DR-XY 44353
|
Perampanel
|
Fycompa
|
2mg
|
Film-Coated Tablet
|
-
|
Eisai Manufacturing Limited
|
United Kingdom
|
Initial from Monitored Release]
|
19 October 2021
|
24 March 2025
|
| View |
|
DR-XY 44354
|
Perampanel
|
Fycompa
|
4mg
|
Film-Coated Tablet
|
-
|
Eisai Manufacturing Limited
|
United Kingdom
|
Initial from Monitored Release]
|
19 October 2021
|
24 March 2025
|
| View |
|
DR-XY 44379
|
Oxaliplatin
|
Vexplatin 50
|
2mg/mL (50mg/25mL)
|
Solution For Iv Infusion
|
-
|
Admac Lifesciences
|
India
|
-
|
11 February 2021
|
26 March 2025
|
| View |
|
DR-XY 44834
|
Metformin Hydrochloride + Pioglitazone ( As Hydrochloride ) + Glimepiride
|
Tripride-2
|
500mg/15 mg /2 mg
|
Tablet
|
Oral Blood Glucose Loweing Drug Combination
|
Micro Labs Limited
|
India
|
Initial [from Monitored Release]
|
03 June 2022
|
02 October 2025
|
| View |
|
DR-XY 45390
|
None
|
Clobetasol Propionate
|
0.5mg/mL (0.05% w/v)
|
Lotion
|
-
|
M.C.B. Dermatological Products
|
Philippines
|
-
|
20 May 2021
|
24 May 2026
|
| View |
|
DR-XY 45878
|
Osimertinib (As Mesylate)
|
Tagrisso
|
80 mg
|
Film-Coated Tablet
|
-
|
AstraZeneca AB
|
Sweden
|
-
|
08 April 2022
|
09 May 2027
|
| View |
|
DR-XY 45879
|
Osimertinib (As Mesylate)
|
Tagrisso
|
40 mg
|
Film-Coated Tablet
|
-
|
AstraZeneca AB
|
Sweden
|
-
|
08 April 2022
|
09 May 2027
|
| View |
|
DR-XY 46236
|
Clobetasol propionate
|
Cleovate
|
500 mcg/g (0.05%w/w))
|
Cream
|
Corticosteroid
|
Curetech Skincare
|
India
|
Automatic Renewal
|
03 December 2021
|
01 February 2025
|
| View |
|
DR-XY 47372
|
Apalutamide
|
Erleada
|
60 mg
|
Film-Coated Tablet
|
Anti-androgen
|
Janssen Ortho LLC
|
United States of America
|
Monitored Release
|
09 September 2021
|
09 September 2024
|
| View |
|
DR-XY 47388
|
Plerixafor
|
Plerifor
|
20 mg/mL (24 mg/1.2 mL)
|
Solution for Subcutaneous Injection
|
-
|
Hetero Labs Limited (Unit-VI)
|
India
|
-
|
15 September 2021
|
15 September 2026
|
| View |
|
DR-XY 47469
|
Prednisolone (as sodium phosphate)
|
None
|
15 mg/5 mL
|
Syrup
|
Corticosteroid
|
Lloyd Laboratories, Inc.
|
Philippines
|
Initial
|
19 October 2021
|
19 October 2026
|
| View |
|
DR-XY 47531
|
Zinc Orotate
|
Zinkorot
|
25mg
|
Tablet
|
-
|
Mauermann - Arzneimittel KG
|
Germany
|
-
|
15 November 2021
|
15 November 2026
|
| View |
|
DR-XY 47564
|
Sucroferric oxyhydroxide
|
Velphoro
|
2.5 g (equivalent to 500 mg Iron)
|
Chewable Tablet
|
Drug for treatment of hyperkalemia and
hyperphosphatemia
|
Corden Pharma Fribourg SA
|
Switzerland
|
Monitored Release (Reconstruction)
|
06 February 2024
|
24 November 2024
|
| View |
|
DR-XY 47568
|
Ticagrelor
|
None
|
60 mg
|
Film-Coated Tablet
|
Antithrombotic Agent (Platelet Aggregation Inhibitor)
|
Lloyd Laboratories, Inc.
|
Philippines
|
Monitored Release
|
29 November 2021
|
29 November 2024
|
| View |
|
DR-XY 47599
|
Sertaconazole nitrate
|
Zalain Ovule
|
300 mg
|
Vaginal Suppository
|
Anti-infective/Antiseptic (Imidazole Derivative)
|
Trommsdorff GmbH & Co. KG
|
Germany
|
Monitored Release
|
10 December 2021
|
10 December 2024
|
| View |
|
DR-XY 47673
|
Letrozole
|
Brezole
|
2.5mg
|
Film Coated Tablet
|
Antineoplastic (Aromatase Inhibitor)
|
Synthon Hispania SL
|
Spain
|
Initial
|
25 January 2022
|
25 January 2027
|
| View |
|
DR-XY 47674
|
Ursodeoxycholic Acid
|
Ursosan
|
250 mg
|
Capsule
|
-
|
PRO.MED.CS Praha A.S.
|
Czech Republic
|
-
|
25 January 2022
|
25 January 2027
|
| View |
|
DR-XY 47704
|
Ibrutinib
|
Imbruvica
|
140 mg
|
Capsule
|
Antineoplastic Agent (Protein Kinase Inhibitor)
|
Cilag AG
|
Switzerland
|
Monitored Release
|
04 February 2022
|
04 February 2027
|
| View |
|
DR-XY 47705
|
Rosuvastatin (as zinc) + Ezetimibe
|
Rozuor
|
10mg/10mg
|
Capsule
|
-
|
EGIS Pharmaceuticals PLC
|
Hungary
|
-
|
04 February 2022
|
04 February 2027
|